Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

This is very big. SARsCoV2 is implicated in viral-induced kidney inflammation leading to exacerbation of AKI with severe acute tubular necrosis. Worsening of oxidative stress is also involved along with microvascular injury. Bril just potentially expanded its clinical application in AKI patients with today's results! ACE2 receptors in kidneys are more prevalent than in lungs, mind you.

The organ crosstalk also happens between injured lungs, kidneys, and heart that worsens their subclinical conditions.